TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited has announced its Annual General Meeting (AGM) will be held virtually on November 26, 2025, allowing shareholders to participate online. The company has set October 8, 2025, as the deadline for director nominations, which must be submitted in writing to their registered office. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and governance.
More about Firebrick Pharma Limited
Firebrick Pharma is a pharmaceutical innovator specializing in the development and commercialization of novel formulations and uses of povidone-iodine (PVP-I). The company has launched its Nasodine Nasal Spray in the United States, Singapore, and Fiji & South Pacific, with plans to enter the Philippine market in 2026.
Average Trading Volume: 84,129
Technical Sentiment Signal: Sell
Learn more about FRE stock on TipRanks’ Stock Analysis page.